Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway
Staurosporine, which is an inhibitor of a broad spectrum of protein kinases, has shown cytotoxicity on several human cancer cells. However, the underlying mechanism is not well understood. In this study, we examined whether and how this compound has an inhibitory action on phosphatidylinositol 3-kin...
Saved in:
| Main Authors: | Youming Ding, Bin Wang, Xiaoyan Chen, Yu Zhou, Jianhui Ge |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317694317 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Improvement of Sepsis-Associated Encephalopathy by P2X7R Inhibitor through Inhibiting the Omi/HtrA2 Apoptotic Signaling Pathway
by: Kaifang Wang, et al.
Published: (2022-01-01) -
Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice.
by: Ellen Gerhardt, et al.
Published: (2011-01-01) -
Cerasus humilis Proanthocyanidins Ameliorats Insulin Resistance through PI3K-Akt-GSK-3β Signaling Pathway in HepG2 Cells
by: Xinhui LIU, et al.
Published: (2025-04-01) -
RETRACTED: Paris saponin VII enhanced the sensitivity of HepG2/ADR cells to ADR via modulation of PI3K/AKT/MAPK signaling pathway
by: Gong‐En Tang, et al.
Published: (2020-02-01) -
Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK–STAT signaling pathway
by: X. Zhu, et al.
Published: (2025-06-01)